NCT07472387 2026-03-16
Andro-iGlio
Assistance Publique - Hôpitaux de Paris
Phase NA Not yet recruiting
Clinical Trials
57 trialsNCT07462507 2026-03-10
Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1
Washington University School of Medicine
Phase 2 Not yet recruiting
NCT07452458 2026-03-05
Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma
NRG Oncology
Phase 3 Not yet recruiting
NCT07443176 2026-03-02
FCI-Glioblastoma Study
University of Aberdeen
Not yet recruiting
NCT07439172 2026-02-27
PRC
The Cooper Health System
Phase 2 Not yet recruiting
NCT07422896 2026-02-20
Bvax
Northwestern University
Phase 1 Not yet recruiting
NCT06448286 2026-02-19
PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma
Jonsson Comprehensive Cancer Center
Phase 3 Not yet recruiting
NCT07375992 2026-02-18
MELODY
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase NA Not yet recruiting
NCT07413796 2026-02-17
NEURO-SUTURE
Medical University of Warsaw
Phase NA Not yet recruiting
NCT07409584 2026-02-13
SHINE-GLIO
University Hospital, Essen
Not yet recruiting
NCT07387666 2026-02-06
Imaging Acetadote Metabolism in Glioblastoma
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Not yet recruiting
NCT07392957 2026-02-06
Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastoma
Washington University School of Medicine
Phase 1/2 Not yet recruiting
NCT07389278 2026-02-05
Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG)
University of California, San Francisco
Phase 1/2 Not yet recruiting
NCT07385846 2026-02-04
Pilot Study of Navigated Focused Ultrasound and Pembrolizumab in the Treatment of Recurrent WHO Grade 4 IDH-Wildtype Glioblastoma With Mismatch Repair Deficiency
University of Cincinnati
Phase 1 Not yet recruiting
NCT07376304 2026-01-29
BrainUS-AI
Hospital del Rio Hortega
Phase 3 Not yet recruiting
NCT07365124 2026-01-26
MRinRT
Swansea Bay University Health Board
Not yet recruiting
NCT07284628 2025-12-16
ReVoGlio
University of Zurich
Phase 2 Not yet recruiting
NCT07244666 2025-11-24
Safety and Preliminary Efficacy of a Metabolically Armed Chimeric Antigen Receptor T Cell Therapy Targeting EGFRvIII for Recurrent Glioblastoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase EARLY_PHASE1 Not yet recruiting
NCT07211841 2025-11-19
GLIOMIT
Centre Hospitalier Universitaire, Amiens
Phase NA Not yet recruiting
NCT04903795 2025-11-03
BRiTE
Duke University
Phase 1 Not yet recruiting
NCT06804655 2025-10-02
EViDENCE-BT
University of Zurich
Phase 2 Not yet recruiting
NCT07197086 2025-09-29
Clinical and Treatment Determinant of Prognosis in Glioblastoma
Assiut University
Not yet recruiting
NCT06492486 2025-09-16
GLADIATOR
Tata Memorial Centre
Phase 2 Not yet recruiting
NCT07173829 2025-09-15
BORDEAUX-GLIO
University Hospital, Bordeaux
Not yet recruiting
NCT07162324 2025-09-09
A Multicenter, Prospective Study for Glioblastoma Patients
Larissa University Hospital
Not yet recruiting
NCT06455189 2025-08-13
Magnetic Resonance Fingerprinting Guided Extended Resection in Glioblastomas
Case Comprehensive Cancer Center
Phase 1 Not yet recruiting
NCT06617208 2025-08-08
PIONEER
Erasmus Medical Center
Phase NA Not yet recruiting
NCT07089758 2025-07-28
A Study for Cerebral Open Flow Microperfusion
Mayo Clinic
Phase NA Not yet recruiting
NCT07052877 2025-07-11
GUAVA
Royal North Shore Hospital
Not yet recruiting
NCT07029100 2025-06-19
ORGA-GLIO
Centre Henri Becquerel
Phase NA Not yet recruiting
NCT01777919 2025-05-25
GLIODIS
Olympion Medical Center
Phase 2 Not yet recruiting
NCT06869577 2025-04-29
SUGRI
Rigshospitalet, Denmark
Phase NA Not yet recruiting
NCT06939400 2025-04-22
Photodynamic Therapy for Glioblastoma Multiforme Based on Metaverse and Yellow Fluorescence
Zhejiang Provincial People's Hospital
Not yet recruiting
NCT06929819 2025-04-16
Research on the Safety and Efficacy of Intraoperative Radiation Therapy in Malignant Cerebral Tumor
First Affiliated Hospital, Sun Yat-Sen University
Phase NA Not yet recruiting
NCT06894225 2025-04-06
Proof-of-Concept Study of ACT001 in Adult Patients With Recurrent Glioblastoma Harbouring STAT3-High Signature
National Neuroscience Institute
Phase 2 Not yet recruiting
NCT06749925 2025-04-01
Clinical Trial Assessing the Efficacy and Safety of Dendritic Cell-Based Immunotherapy for Glioblastoma
University of Sao Paulo General Hospital
Phase 3 Not yet recruiting
NCT06781372 2025-03-13
GlioPDO
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase NA Not yet recruiting
NCT06845020 2025-02-25
CSF Proteomic Characterization of Glioblastomas
Univeridad Autonoma de Guadalajara
Not yet recruiting
NCT06780592 2025-01-22
Vebreltinib Combined With Temozolomide for Glioblastoma (GBM) After Surgery
Huashan Hospital
Phase 2 Not yet recruiting
NCT06764537 2025-01-08
BOOSTCAR
Central Hospital, Nancy, France
Phase NA Not yet recruiting
NCT06684899 2024-11-14
KillGlio
IRCCS San Raffaele
Not yet recruiting
NCT06657027 2024-10-24
ARTPLAN-GLIO
Hospital del Rio Hortega
Not yet recruiting
NCT06466031 2024-07-30
Application of MET-PET in Fusion With MRI in the Treatment of Glioblastoma Multiforme
Copernicus Memorial Hospital
Phase NA Not yet recruiting
NCT06477939 2024-06-27
THREE-GLEES
Institut de cancérologie Strasbourg Europe
Phase 3 Not yet recruiting
NCT06136611 2024-06-24
PORTRAIT
The Christie NHS Foundation Trust
Phase NA Not yet recruiting
NCT05500612 2024-06-06
MANGO
University of Sydney
Not yet recruiting
NCT06368934 2024-04-16
Sub-lobectomy for IDH Wild-type and TERT Promoter Mutant Glioblastoma
Huashan Hospital
Phase NA Not yet recruiting
NCT06218524 2024-01-23
The Effectiveness of HP and TMZ Synergism on Adult Recurrence GBM
Southern Medical University, China
Phase 2 Not yet recruiting
NCT05820191 2023-12-21
B-amyloid as a Marker for GBM Bioimaging
Universidad Central del Caribe
Phase 2 Not yet recruiting
NCT06132438 2023-11-15
Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma
The University of New South Wales
Phase 1 Not yet recruiting